Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Proactive will provide editorial coverage of BetterLife’s news releases, generate feature articles based on interviews with company executives
  • Psychedelic Finance will provide an expanded marketing campaign, including social media support, market performance and news features
  • BetterLife Pharma Inc. is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals
  • BetterLife Pharma Inc. (BETR) is up 8.77 per cent and is trading at C$0.31 at 12:07 pm ET

BetterLife Pharma Inc. (BETR) has retained Proactive Investors and psychedelic finance to broaden its reach with global investors and build market awareness.

Proactive will provide editorial coverage of BetterLife’s news releases, generate feature articles based on interviews with company executives, and produce video interviews.

With six offices on three continents and a team of experienced business journalists and broadcasters, Proactive works with innovative growth companies quoted on the world’s major stock exchanges, helping executives engage with investors.

Psychedelic Finance will provide an expanded marketing campaign, including social media support, market performance and news features.

Proactive Investors enable companies and investors to connect intelligently.

Proactive is one of the fastest-growing financial media portals in the world, providing breaking news, commentary and analysis on hundreds of listed companies and pre-IPO businesses across the globe, 24/7.

Psychedelic Finance operates a marketing company for its private and public partners, building strategic campaigns leveraging video, media and strategic introductions to its network.

BetterLife Pharma Inc. is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies.

BetterLife Pharma Inc. (BETR) is up 8.77 per cent and is trading at C$0.31 at 12:07 pm ET.

More From The Market Herald

" Hemostemix (TSXV:HEM) announces non-brokered private placement

Hemostemix (HEM) has announced a non-brokered private placement of up to 15 million units.
WELL Health - Chairman & CEO Hamed Shahbazi

" WELL Health (TSX:WELL) closes $34.5M public offering

WELL Health Technologies Corp. (WELL) has completed a bought deal public offering for proceeds of $34.5 million.

" Simply Better Brands (TSXV:SBBC) enters the weight loss category

Simply Better Brands (SBBC) has launched its entry into the weight loss category with a PureKana Keto Gummy.

" Cardiol Therapeutics (TSX:CRDL) appoints new directors

Cardiol Therapeutics (CRDL) has appointed Teri Loxam and Chris Waddick to its Board of Directors, effective immediately.